Eczema

A systematic review and meta-analysis of the regional and age-related differences in atopic dermatitis clinical characteristics

Due to previous studies producing “conflicting results about ...

Dupilumab therapy provides clinically meaningful improvement in patient-reported outcomes (PROs): A phase IIb, randomized, placebo-controlled, clinical trial in adult patients with moderate to severe atopic dermatitis (AD)

Patients with atopic dermatitis (AD) are significantly burdened ...

Severe atopic dermatitis guidelines developed

According to recent guidelines developed and published in ...

Comment on: “When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema Council”

Recommendations offered about when atopic dermatitis (AD) warrants ...

Study tests the use of Eczema Action Plans (EAPs) to improve parental understanding of treatment regimens in pediatric atopic dermatitis (AD)

An action plan for atopic dermatitis (AD) similar ...

Three patients treated with Dupilumab for hand eczema

Hand eczema affects about 10% of the general ...

Novel molecular disease classifier developed for eczema and psoriasis

Eczema and psoriasis are complex inflammatory skin diseases ...

Four-week study examines quality of life impact of skin care regimen on eczema sufferers

The common skin care regimen for an adult ...

Phosphodiesterase 4 inhibitors a promising alternative to topical corticosteroids

Historically, atopic dermatitis (AD) has been treated with ...

Atopic dermatitis: Systemic antihistamines

Although antihistamines may be useful for treating sleep ...